Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Help Edwarda - Post Clues About Edwarda -- Ignore unavailable to you. Want to Upgrade?

To: Rick Julian who wrote (33)	6/18/2000 2:23:00 PM
From: Crocodile	Read Replies (1) \| Respond to of 75

Actually, the part that I didn't like the sound of was: "Additional signs of ephedrine toxicity include nausea, vomiting, headache, flushing, paresthesias, difficulty in micturation and precordial pain.(11,14) Patients with sympathomimetic toxicity are at an increased risk of rhabdomyolysis.(13) It has also been suggested that sympathomimetic drugs may precipitate thyroid storm in individuals with thyrotoxicosis.(17)" Those are the symptoms that I've actually been hearing about in relation to ephedra rather than the cardiac-related symptoms.